Editor(s):
(1) Dr. Anjaneyulu Vinukonda, Strides Pharma Inc., USA.
Reviewers:
(1) Rashidat Oluwabukola Owolabi, Emirates College of Health Sciences and Technology, Nigeria.
(2) Moaz Abouelmagd, Cairo University, Egypt.
(3) Zhihui Wang, University of Rochester, USA.
(4) Deepak Kajla, Gurugram Global College of Pharmacy, India.
Additional Reviewers:
Additional Reviewers: (Comments received after deadline)
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 7.98/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer Review Report_1 (Rashidat Oluwabukola Owolabi, Nigeria) | File 1 | File 2
Stage 2 | Peer Review Report_2 (Moaz Abouelmagd, Egypt) | File 1 | NA
Stage 2 | Peer Review Report_3 (Zhihui Wang, USA) | File 1 | NA
Stage 2 | Peer Review Report_4 (Deepak Kajla, India) | File 1 | File 2
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA
Stage 3 | Revised_MS_v2_and_Feedback_v2 | File 1 | NA
Stage 3 | Comment_Editor_1_v2 | File 1 | NA